Astera Labs, Inc.

$ALAB – Impulse Complete or Just a Deep Wave-4?

91
After a massive 5-wave run from $47 → $262, Astera Labs (ALAB) is showing the first real signs of exhaustion.
The key question now: is this a larger ABC correction, or just a Wave-4 pause before a final push higher?
Structure
  • Price turned lower after rejecting the upper channel resistance.
  • The decline looks impulsive, with expanding volume — more typical of a Wave-A than a shallow pullback.

Momentum
  • RSI collapsed to around 34, showing strong downside momentum. Wave-4 corrections usually stall near 40–45, so this leans bearish.
  • MACD turned negative and diverging — consistent with the start of a broader correction.

Key Levels
  • $175–$185 → Resistance area for a potential Wave-B bounce
  • $135–$140 → 0.382 Fib – first meaningful support
  • $111 → 0.5 Fib – midpoint target for Wave-C
    []$90 → 0.618 Fib – ideal capitulation zone and long-term buy area

Scenarios

🟢 Bullish (40%) – Wave-4 before Wave-5
  • Consolidation above $135 and RSI basing near 35–40 could trigger a rebound.
  • Confirmation comes on a break and close above $185 → potential Wave-5 rally toward $320–$350.

🔴 Bearish (60%) – Larger ABC correction
  • Failure to hold $135 → next leg down toward $110–$90 (Wave-C).
  • Would reset the structure before a new long-term impulse begins.

Summary
Momentum and structure currently favor a larger ABC correction rather than a shallow Wave-4.
Expect a short-term bounce (Wave-B), followed by a potential retest of the $110–$90 zone later this cycle.
A new bullish phase likely begins once RSI forms bullish divergence and price starts reclaiming higher highs.

Outlook
  • Short-term: bearish pressure / corrective phase
  • Medium-term: base expected Q1–Q2 2026
  • Long-term: bullish continuation once correction completes

What’s your take: early stages of Wave-C, or will buyers defend the 0.382?

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.